Ovid Therapeutics Inc. · NASDAQ:OVID
Sirenia Capital Management LP reported a 9.90% stake in Ovid Therapeutics Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
Sirenia Capital Management LP reported a 9.90% stake in Ovid Therapeutics Inc., 18,031,333 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 18,031,333
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sirenia Capital Management LP | 9.90% | 18,031,333 |
| Alex Silverstein | 9.90% | 18,031,333 |
Source
Related
- Ovid Therapeutics Inc.
- Sirenia Capital Management LP
- Ovid Therapeutics Inc. shareholders
- Schedule 13G/A · Eventide Asset Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026